Chase W. Nelson 倪誠志 Profile picture
Jun 16, 2021 5 tweets 3 min read Read on X
TODAY’S (6月16日) #COVID19 update for #Taiwan 🇹🇼
📈167 local + 3 imported cases 📉trend
📈18 deaths 📉trend
📉0.5% test positive rate
📈3.7% case fatality rate (CFR) since May 1
🧪34k tests 📉capacity
💡Dropping test numbers hopefully temporary due to weekend and holiday. 1/5 Image
DAILY CASES REPORTED (pink bars) and their 7-DAY AVERAGE (pink line), where each day is the mean of itself and the previous six. Reported DEATHS (crimson red bars) are seen at the bottom. For deaths from May 1-June 16:
🔴64% are ≥70
🔴26% are 60-69
🔴10% are 30-59 years old
2/5 Image
AGE DISTRIBUTION OF CASES. Local cases from May 1-June 15 (age data for cases lag by a day), including those with missing locations. Only a single category is provided for ages >70, which constitute 14% of all cases. ➡️data.cdc.gov.tw/en/dataset/ags… 3/5 Image
Our local case fatality rate for May 1-June 15 is 3.7%—higher than the world average of 1-3%. This is at least partly due to a disproportionate number of older cases.
💡For those skeptical of the 3.7%, VP Chen 陳建仁 reports the same number here ➡️facebook.com/chencj/posts/4…
4/5 Image
CASES & DEATHS and their 7-DAY AVERAGE BY AGE for May 1-June 15 (the latest age-matched data available).
💡I am NOT aware of any clinical trials testing the effects or safety of a third vaccine dose (e.g., against the Delta variant), as suggested by some politicians. 5/5 Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Chase W. Nelson 倪誠志

Chase W. Nelson 倪誠志 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @chasewnelson

Jun 11, 2023
My first #COVID19🦠 infection: a description.

SUMMARY: I was positive for 12 days. Day 1 had debilitating headache, fever, and fatigue. I was functional by day 5, followed by steady improvement. Post-nasal drip continues to the present, weeks later.

Some observations. 1/11
ME: male, 34yo, healthy, 4x vaccinated. My last boost (Moderna 2v) was 252 days before getting infected.

VIRUS: likely Omicron XBB or BA.2.75.

WHAT HELPED: Advil, neti pot, water, sleep, vitamins, fruit. Lemon, honey, cinnamon, and a dash of cayenne pepper in warm water. 2/11 Image
WHERE ACQUIRED: unknown. Suspect a coffeeshop 4 days prior, where several individuals were coughing, some maskless.

DAY 0: the day before I fell ill, I had throat discomfort, as if a piece of food were stuck in tonsil area. This abated midday and I thought all was well. 3/11 Image
Read 11 tweets
Mar 22, 2023
Nice science by @flodebarre & team in the raccoon dog report, providing important details and (in my view) weak evidence for a wildlife origin of SARS-CoV-2.

However, relevant evidence and reasons for preferring scenario A over B below are not discussed & I remain agnostic.
1/14
Favoring a wildlife origin (scenario A), I found the following most compelling:
🔹SARS-CoV-2+ environmental samples are clustered in the area where susceptible wildlife were held
🔹sample Q61 contained sequence with 100% match to raccoon dog but none with 100% match to human
2/14
Unfortunately, sampling locations were not randomly distributed, but were intentionally concentrated in the area with susceptible wildlife.

Because all samples are spatially concentrated, positive samples are spatially concentrated.

Thus, I find this point to be circular.
3/14
Read 14 tweets
Jun 1, 2022
Data from the @TaiwanCDC confirm that #COVID19 vaccines help against #Omicron.

Specifically, the rate of death decreases with each additional vaccine dose, for every age group in the population.

This is despite numerous assumptions biased against vaccine effectiveness.
1/13
First, consider the population of Taiwan, stratified by age and vaccination status. The single largest group is 30-49 year-olds with 3 doses (dark green).

This is the pattern of deaths one would expect if deaths were random, i.e., if both vaccination and age had no effect.
2/13
Second, consider the observed deaths. The single largest group is 75+ year-olds with 0 doses.

Thus, the observed pattern of deaths differs drastically from random expectation.

For example, 75+ year-olds with 0 doses are a small demographic but dominate the deaths.
3/13
Read 17 tweets
May 10, 2022
I was recently fortunate to be interviewed by @niccijsmith at @TelGlobalHealth regarding #Taiwan's #COVID situation.

Unfortunately, certain media outlets used my observations to play politics.

Instead of spreading hype, here's what I wish they'd covered.
1/
Everyone should know:
1⃣COVID is airborne
2⃣the top symptoms of COVID-19 resemble a cold
3⃣some people develop long COVID
4⃣risks from COVID-19 vs. vaccines
5⃣rapid antigen tests are a good indicator of whether you're contagious, but can be negative even when you’re infected
2/
Some good news:
1⃣the population of Taiwan is relatively freshly vaccinated
2⃣Omicron may be slightly less severe than previous variants, like Delta (but remains highly dangerous to the unvaccinated)
3⃣Taiwan has antiviral medications
3/
Read 9 tweets
Dec 24, 2021
In a world with #Omicron (a rare mutational event), the drug #molnupiravir (a mutagen) was just authorized by the @US_FDA despite:

1⃣ NO estimate of the number of mutations it causes per virus

2⃣ NO estimate of onward viral transmission while on the drug
fda.gov/news-events/pr…
@US_FDA Given #molnupiravir's usage to treat #COVID19 is inevitable, what can be done to prevent the potential acceleration of #SARSCoV2 variants?
1⃣patients should strictly ISOLATE WHILE TAKING, especially in the first days on the drug

2⃣ALL DOSES should be taken PRECISELY as directed
@US_FDA Our own reasons for these recommendations are presented here 👇
Read 5 tweets
Dec 2, 2021
🧵The @US_FDA's materials on @Merck's #Molnupiravir and its potential to induce problematic #SARSCoV2 variants are HERE:

📄section 4.3.2.5 (pp. 30-36)
👉fda.gov/media/154418/d…

📺at 2h51m, 3h46m, 4h5m, 5h12m, 7h32m
👉

Observations to follow.
1/n
@US_FDA @Merck First, @Merck and the @US_FDA panelists have done excellent work compiling and analyzing the available data. This was not an easy vote (13 YES/10 NO).

However, specifically on the potential for molnupiravir to induce new viral variants, the results only augment my concerns.
2/n
@US_FDA @Merck 1⃣MUTATION VS. SELECTION. The materials repeatedly confuse mutation and selection (e.g., "The Spike protein is already under evolutionary pressure with or without molnupiravir", 3hr).

Contrarily, the concern is this drug is a mutagen and provides RAW MATERIAL, not selection.
3/n Image
Read 15 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(